Aligned Genetics Inc (238120) — Cash Flow Reinvestment Rate
Aligned Genetics Inc (238120) has a Cash Flow Reinvestment Rate of 0.39x as of June 2025, reinvesting ₩265.20 Million (capex ₩165.20 Million plus investments ₩100.00 Million) from operating cash flow of ₩677.20 Million. See Aligned Genetics Inc (238120) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Aligned Genetics Inc Cash Flow Reinvestment Rate (2019–2024)
Historical reinvestment intensity for Aligned Genetics Inc across 6 annual periods. For the full cash flow conversion analysis, see Aligned Genetics Inc cash flow conversion.
Annual Cash Flow Reinvestment Rate for Aligned Genetics Inc (2019–2024)
Year-by-year capital reinvestment analysis for Aligned Genetics Inc. See 238120 financial flexibility score to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 2.57x | ₩7.89 Billion | ₩3.07 Billion | ₩340.06 Million | ▲ +237.6% |
| 2023 | 0.76x | ₩2.17 Billion | ₩2.85 Billion | ₩880.42 Million | ▼ -71.8% |
| 2022 | 2.70x | ₩6.00 Billion | ₩2.22 Billion | ₩2.00 Billion | ▼ -89.7% |
| 2021 | 26.15x | ₩3.56 Billion | ₩135.97 Million | ₩3.31 Billion | ▲ +17.1% |
| 2020 | 22.33x | ₩796.38 Million | ₩35.67 Million | ₩96.43 Million | ▲ +655.8% |
| 2019 | 2.95x | ₩1.95 Billion | ₩659.29 Million | ₩261.62 Million | — |